148 related articles for article (PubMed ID: 8809470)
1. Tumor necrosis factor: function, release and clearance.
Bemelmans MH; van Tits LJ; Buurman WA
Crit Rev Immunol; 1996; 16(1):1-11. PubMed ID: 8809470
[TBL] [Abstract][Full Text] [Related]
2. Tumor Necrosis Factor: Function, Release and Clearance.
Bemelmans MHA; van Tits LJH; Buurman WA
Crit Rev Immunol; 2017; 37(2-6):249-259. PubMed ID: 29773022
[TBL] [Abstract][Full Text] [Related]
3. Influence of nephrectomy on tumor necrosis factor clearance in a murine model.
Bemelmans MH; Gouma DJ; Buurman WA
J Immunol; 1993 Mar; 150(5):2007-17. PubMed ID: 8436831
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
Terlizzese M; Simoni P; Antonetti F
J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
[TBL] [Abstract][Full Text] [Related]
5. Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice.
Huaux F; Arras M; Vink A; Renauld JC; Lison D
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):137-45. PubMed ID: 10385602
[TBL] [Abstract][Full Text] [Related]
6. Expression and cleavage of tumor necrosis factor-alpha and tumor necrosis factor receptors by human monocytic cell lines upon direct contact with stimulated T cells.
Vey E; Burger D; Dayer JM
Eur J Immunol; 1996 Oct; 26(10):2404-9. PubMed ID: 8898953
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.
Evans TJ; Moyes D; Carpenter A; Martin R; Loetscher H; Lesslauer W; Cohen J
J Exp Med; 1994 Dec; 180(6):2173-9. PubMed ID: 7964492
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
[TBL] [Abstract][Full Text] [Related]
9. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
[TBL] [Abstract][Full Text] [Related]
10. In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies.
Bemelmans MH; Abramowicz D; Gouma DJ; Goldman M; Buurman WA
J Immunol; 1994 Jul; 153(2):499-506. PubMed ID: 8021491
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration.
Slowik MR; De Luca LG; Fiers W; Pober JS
Am J Pathol; 1993 Dec; 143(6):1724-30. PubMed ID: 7504889
[TBL] [Abstract][Full Text] [Related]
12. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
Butler DM; Feldmann M; Di Padova F; Brennan FM
Eur Cytokine Netw; 1994; 5(5):441-8. PubMed ID: 7880974
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.
Sheehan KC; Pinckard JK; Arthur CD; Dehner LP; Goeddel DV; Schreiber RD
J Exp Med; 1995 Feb; 181(2):607-17. PubMed ID: 7836916
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
[TBL] [Abstract][Full Text] [Related]
15. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
Bemelmans MH; Gouma DJ; Buurman WA
J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
[TBL] [Abstract][Full Text] [Related]
16. TNF-Induced shedding of TNF receptors in human polymorphonuclear leukocytes: role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase.
Dri P; Gasparini C; Menegazzi R; Cramer R; Albéri L; Presani G; Garbisa S; Patriarca P
J Immunol; 2000 Aug; 165(4):2165-72. PubMed ID: 10925303
[TBL] [Abstract][Full Text] [Related]
17. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
18. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
Steinshamn S; Bemelmans MH; Buurman WA; Waage A
Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of eosinophilic inflammation in allergen-challenged TNF receptor p55/p75--and TNF receptor p55-deficient mice.
Broide DH; Stachnick G; Castaneda D; Nayar J; Sriramarao P
Am J Respir Cell Mol Biol; 2001 Mar; 24(3):304-11. PubMed ID: 11245629
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
Warzocha K; Bienvenu J; Coiffier B; Salles G
Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
